Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Laryngoscope. 2011 May;121(5):978–982. doi: 10.1002/lary.21724

Figure 2.

Figure 2

Kaplan-Meier curves of survival comparison between control and sirolimus-treated FaDu xenograft mice in MRD. Mice were sacrificed due to significant tumor burden (>2,000 mm3), weight loss >15%, or at maximum time point of 30 days after the treatment initiation. Sirolimus (5 mg/kg) significantly improved survival compared to control (p<0.01).